Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics

Susan E. McCann, Katie C. Hootman, Anne M. Weaver, Lilian U. Thompson, Carl Morrison, Helena Hwang, Stephen B. Edge, Christine B. Ambrosone, Peter J. Horvath, Swati A. Kulkarni

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Dietary lignans may affect breast cancer by modifying tumor characteristics likely to affect prognosis. We investigated usual dietary intakes of total and specific lignans with tumor characteristics in 683 women with breast cancer and 611 healthy women without breast cancer enrolled in the Data Bank and BioRepository at Roswell Park Cancer Institute (RPCI). Clinicopathologic data were abstracted from the RPCI breast cancer database. Dietary lignan intakes were calculated from FFQ. OR and 95% CI were estimated with logistic regression adjusting for potential confounders and stratified by menopausal status. Women in the highest compared to the lowest tertile of total lignan intakes had a 40-50% lower odds of breast cancer regardless of menopausal status and substantially reduced odds of an invasive tumor, especially among premenopausal women [OR 0.48 (95% CI 0.26-0.86)]. Lignan intakes were inversely associated with odds of grade 3 tumors among premenopausal women. Lignan intakes were inversely associated with risk of estrogen receptor (ER) negative (ER -) breast cancer among premenopausal women [OR 0.16 (95% CI 0.03-0.44)] and particularly triple negative tumors [ER -, progesterone receptor negative, HER2 negative; OR 0.16 (95% CI 0.04-0.62)]. There were significant differences in the contribution to these effects by specific lignans, especially matairesinol and lariciresinol. In summary, in this case-control study of dietary lignan intakes and breast cancer, we found that higher lignan intakes were associated with lower risks of breast cancer with more favorable prognostic characteristics. Future investigations are warranted to explore the strong associations observed with ER - cancer in premenopausal women.

Original languageEnglish (US)
Pages (from-to)91-98
Number of pages8
JournalJournal of Nutrition
Volume142
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Lignans
Breast Neoplasms
Estrogen Receptors
Neoplasms
Databases
Progesterone Receptors
Case-Control Studies
Logistic Models

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

McCann, S. E., Hootman, K. C., Weaver, A. M., Thompson, L. U., Morrison, C., Hwang, H., ... Kulkarni, S. A. (2012). Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. Journal of Nutrition, 142(1), 91-98. https://doi.org/10.3945/jn.111.147264

Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. / McCann, Susan E.; Hootman, Katie C.; Weaver, Anne M.; Thompson, Lilian U.; Morrison, Carl; Hwang, Helena; Edge, Stephen B.; Ambrosone, Christine B.; Horvath, Peter J.; Kulkarni, Swati A.

In: Journal of Nutrition, Vol. 142, No. 1, 01.01.2012, p. 91-98.

Research output: Contribution to journalArticle

McCann, SE, Hootman, KC, Weaver, AM, Thompson, LU, Morrison, C, Hwang, H, Edge, SB, Ambrosone, CB, Horvath, PJ & Kulkarni, SA 2012, 'Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics', Journal of Nutrition, vol. 142, no. 1, pp. 91-98. https://doi.org/10.3945/jn.111.147264
McCann, Susan E. ; Hootman, Katie C. ; Weaver, Anne M. ; Thompson, Lilian U. ; Morrison, Carl ; Hwang, Helena ; Edge, Stephen B. ; Ambrosone, Christine B. ; Horvath, Peter J. ; Kulkarni, Swati A. / Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics. In: Journal of Nutrition. 2012 ; Vol. 142, No. 1. pp. 91-98.
@article{9f84dfd6eec745199bf1d439cb77b059,
title = "Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics",
abstract = "Dietary lignans may affect breast cancer by modifying tumor characteristics likely to affect prognosis. We investigated usual dietary intakes of total and specific lignans with tumor characteristics in 683 women with breast cancer and 611 healthy women without breast cancer enrolled in the Data Bank and BioRepository at Roswell Park Cancer Institute (RPCI). Clinicopathologic data were abstracted from the RPCI breast cancer database. Dietary lignan intakes were calculated from FFQ. OR and 95{\%} CI were estimated with logistic regression adjusting for potential confounders and stratified by menopausal status. Women in the highest compared to the lowest tertile of total lignan intakes had a 40-50{\%} lower odds of breast cancer regardless of menopausal status and substantially reduced odds of an invasive tumor, especially among premenopausal women [OR 0.48 (95{\%} CI 0.26-0.86)]. Lignan intakes were inversely associated with odds of grade 3 tumors among premenopausal women. Lignan intakes were inversely associated with risk of estrogen receptor (ER) negative (ER -) breast cancer among premenopausal women [OR 0.16 (95{\%} CI 0.03-0.44)] and particularly triple negative tumors [ER -, progesterone receptor negative, HER2 negative; OR 0.16 (95{\%} CI 0.04-0.62)]. There were significant differences in the contribution to these effects by specific lignans, especially matairesinol and lariciresinol. In summary, in this case-control study of dietary lignan intakes and breast cancer, we found that higher lignan intakes were associated with lower risks of breast cancer with more favorable prognostic characteristics. Future investigations are warranted to explore the strong associations observed with ER - cancer in premenopausal women.",
author = "McCann, {Susan E.} and Hootman, {Katie C.} and Weaver, {Anne M.} and Thompson, {Lilian U.} and Carl Morrison and Helena Hwang and Edge, {Stephen B.} and Ambrosone, {Christine B.} and Horvath, {Peter J.} and Kulkarni, {Swati A.}",
year = "2012",
month = "1",
day = "1",
doi = "10.3945/jn.111.147264",
language = "English (US)",
volume = "142",
pages = "91--98",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "1",

}

TY - JOUR

T1 - Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics

AU - McCann, Susan E.

AU - Hootman, Katie C.

AU - Weaver, Anne M.

AU - Thompson, Lilian U.

AU - Morrison, Carl

AU - Hwang, Helena

AU - Edge, Stephen B.

AU - Ambrosone, Christine B.

AU - Horvath, Peter J.

AU - Kulkarni, Swati A.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Dietary lignans may affect breast cancer by modifying tumor characteristics likely to affect prognosis. We investigated usual dietary intakes of total and specific lignans with tumor characteristics in 683 women with breast cancer and 611 healthy women without breast cancer enrolled in the Data Bank and BioRepository at Roswell Park Cancer Institute (RPCI). Clinicopathologic data were abstracted from the RPCI breast cancer database. Dietary lignan intakes were calculated from FFQ. OR and 95% CI were estimated with logistic regression adjusting for potential confounders and stratified by menopausal status. Women in the highest compared to the lowest tertile of total lignan intakes had a 40-50% lower odds of breast cancer regardless of menopausal status and substantially reduced odds of an invasive tumor, especially among premenopausal women [OR 0.48 (95% CI 0.26-0.86)]. Lignan intakes were inversely associated with odds of grade 3 tumors among premenopausal women. Lignan intakes were inversely associated with risk of estrogen receptor (ER) negative (ER -) breast cancer among premenopausal women [OR 0.16 (95% CI 0.03-0.44)] and particularly triple negative tumors [ER -, progesterone receptor negative, HER2 negative; OR 0.16 (95% CI 0.04-0.62)]. There were significant differences in the contribution to these effects by specific lignans, especially matairesinol and lariciresinol. In summary, in this case-control study of dietary lignan intakes and breast cancer, we found that higher lignan intakes were associated with lower risks of breast cancer with more favorable prognostic characteristics. Future investigations are warranted to explore the strong associations observed with ER - cancer in premenopausal women.

AB - Dietary lignans may affect breast cancer by modifying tumor characteristics likely to affect prognosis. We investigated usual dietary intakes of total and specific lignans with tumor characteristics in 683 women with breast cancer and 611 healthy women without breast cancer enrolled in the Data Bank and BioRepository at Roswell Park Cancer Institute (RPCI). Clinicopathologic data were abstracted from the RPCI breast cancer database. Dietary lignan intakes were calculated from FFQ. OR and 95% CI were estimated with logistic regression adjusting for potential confounders and stratified by menopausal status. Women in the highest compared to the lowest tertile of total lignan intakes had a 40-50% lower odds of breast cancer regardless of menopausal status and substantially reduced odds of an invasive tumor, especially among premenopausal women [OR 0.48 (95% CI 0.26-0.86)]. Lignan intakes were inversely associated with odds of grade 3 tumors among premenopausal women. Lignan intakes were inversely associated with risk of estrogen receptor (ER) negative (ER -) breast cancer among premenopausal women [OR 0.16 (95% CI 0.03-0.44)] and particularly triple negative tumors [ER -, progesterone receptor negative, HER2 negative; OR 0.16 (95% CI 0.04-0.62)]. There were significant differences in the contribution to these effects by specific lignans, especially matairesinol and lariciresinol. In summary, in this case-control study of dietary lignan intakes and breast cancer, we found that higher lignan intakes were associated with lower risks of breast cancer with more favorable prognostic characteristics. Future investigations are warranted to explore the strong associations observed with ER - cancer in premenopausal women.

UR - http://www.scopus.com/inward/record.url?scp=84855533760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855533760&partnerID=8YFLogxK

U2 - 10.3945/jn.111.147264

DO - 10.3945/jn.111.147264

M3 - Article

C2 - 22113872

AN - SCOPUS:84855533760

VL - 142

SP - 91

EP - 98

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 1

ER -